Drugs /

exablate 4000 type 2.0

Back to Drugs List

Overview

NCI Definition [1]:
A proprietary device that uses focused ultrasound to induce disruption of the blood-brain barrier.

Clinical Trials

View Clinical Trials for exablate 4000 type 2.0

Exablate 4000 type 2.0 has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating exablate 4000 type 2.0, 1 is phase 1/phase 2 (1 open).

Glioblastoma is the most common disease being investigated in exablate 4000 type 2.0 clinical trials [2].

Drug Details

Synonyms [2]:
exablate neuro, exablate 4000 - type 2, exablate
NCIT ID [1]:
C168546

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.